Dr. Krenitsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
815 Water Street Unit 711
Tampa, FL 33602Phone+1 570-878-8810
Education & Training
Geisinger Health SystemInternship, Pediatrics, 2020 - 2021
Commonwealth Medical CollegeClass of 2020
Clinical Trials
- This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). Start of enrollment: 2019 Jan 31
- Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2019 Feb 27
- Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL Start of enrollment: 2017 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMetastatic prostate cancer masquerading as lymphangioma circumscriptum.Caroline A Gerhardt, Amanda Krenitsky, Sairekha Ravichandran, Sarah Moore, Kenneth Y Tsai
JAAD Case Reports. 2022-04-01 - 4 citationsErythema Ab Igne: A Clinical Review.Christina L Harview, Amanda Krenitsky
Cutis. 2023-04-01 - 7 citationsUpdate in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.Amanda Krenitsky, Skylar Klager, Leigh Hatch, Carlos Sarriera-Lazaro, Pei Ling Chen
American Journal of Clinical Dermatology. 2022-09-01
Press Mentions
The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma PatientsFebruary 7th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
